FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W1948745084> ?p ?o ?g. }

• W1948745084 abstract "Hypertension is a prominent preventable cause of premature morbidity and mortality. People with hypertension and established cardiovascular disease are at particularly high risk, so reducing blood pressure below standard targets may be beneficial. This strategy could reduce cardiovascular mortality and morbidity but could also increase adverse events. The optimal blood pressure target in people with hypertension and established cardiovascular disease remains unknown.To determine if 'lower' blood pressure targets (≤ 135/85 mmHg) are associated with reduction in mortality and morbidity as compared with 'standard' blood pressure targets (≤ 140 to 160/ 90 to 100 mmHg) in the treatment of people with hypertension and a history of cardiovascular disease (myocardial infarction, angina, stroke, peripheral vascular occlusive disease).The Cochrane Hypertension Information Specialist searched the following databases for randomized controlled trials up to February 2017: the Cochrane Hypertension Specialised Register, the Cochrane Central Register of Controlled Trials (CENTRAL), MEDLINE (from 1946), Embase (from 1974), the World Health Organization International Clinical Trials Registry Platform, and ClinicalTrials.gov. We also searched the Latin American and Caribbean Health Science Literature Database (from 1982) and contacted authors of relevant papers regarding further published and unpublished work. There were no language restrictions.We included randomized controlled trials (RCTs) with more than 50 participants per group and at least six months follow-up. Trial reports needed to present data for at least one primary outcome (total mortality, serious adverse events, total cardiovascular events, cardiovascular mortality). Eligible interventions were lower target for systolic/diastolic blood pressure (≤ 135/85 mmHg) compared with standard target for blood pressure (≤ 140 to 160/90 to 100 mmHg).Participants were adults with documented hypertension or who were receiving treatment for hypertension and cardiovascular history for myocardial infarction, stroke, chronic peripheral vascular occlusive disease or angina pectoris.Two review authors independently assessed search results and extracted data using standard methodological procedures expected by The Cochrane Collaboration.We included six RCTs that involved a total of 9795 participants. Mean follow-up was 3.7 years (range 1.0 to 4.7 years). Five RCTs provided individual patient data for 6775 participants.We found no change in total mortality (RR 1.05, 95% CI 0.90 to 1.22) or cardiovascular mortality (RR 0.96, 95% CI 0.77 to 1.21; moderate-quality evidence). Similarly, no differences were found in serious adverse events (RR 1.02, 95% CI 0.95 to 1.11; low-quality evidence). There was a reduction in fatal and non fatal cardiovascular events (including myocardial infarction, stroke, sudden death, hospitalization or death from congestive heart failure) with the lower target (RR 0.87, 95% CI 0.78 to 0.98; ARR 1.6% over 3.7 years; low-quality evidence). There were more participant withdrawals due to adverse effects in the lower target arm (RR 8.16, 95% CI 2.06 to 32.28; very low-quality evidence). Blood pressures were lower in the lower' target group by 9.5/4.9 mmHg. More drugs were needed in the lower target group but blood pressure targets were achieved more frequently in the standard target group.No evidence of a difference in total mortality and serious adverse events was found between treating to a lower or to a standard blood pressure target in people with hypertension and cardiovascular disease. This suggests no net health benefit from a lower systolic blood pressure target despite the small absolute reduction in total cardiovascular serious adverse events. There was very limited evidence on adverse events, which lead to high uncertainty. At present there is insufficient evidence to justify lower blood pressure targets (≤ 135/85 mmHg) in people with hypertension and established cardiovascular disease. More trials are needed to answer this question." @default.
• W1948745084 created "2016-06-24" @default.
• W1948745084 creator A5004419394 @default.
• W1948745084 creator A5010307101 @default.
• W1948745084 creator A5013056953 @default.
• W1948745084 creator A5029690041 @default.
• W1948745084 creator A5067000131 @default.
• W1948745084 creator A5071254204 @default.
• W1948745084 date "2017-10-11" @default.
• W1948745084 modified "2023-09-23" @default.
• W1948745084 title "Blood pressure targets for the treatment of people with hypertension and cardiovascular disease" @default.
• W1948745084 cites W1480729244 @default.
• W1948745084 cites W1617145133 @default.
• W1948745084 cites W1709919176 @default.
• W1948745084 cites W1712642890 @default.
• W1948745084 cites W1908289777 @default.
• W1948745084 cites W1924841915 @default.
• W1948745084 cites W1966479854 @default.
• W1948745084 cites W1970475964 @default.
• W1948745084 cites W1970629917 @default.
• W1948745084 cites W1987864685 @default.
• W1948745084 cites W1990908213 @default.
• W1948745084 cites W2000009266 @default.
• W1948745084 cites W2004122631 @default.
• W1948745084 cites W2006918689 @default.
• W1948745084 cites W2009917149 @default.
• W1948745084 cites W2021334280 @default.
• W1948745084 cites W2021988356 @default.
• W1948745084 cites W2023144631 @default.
• W1948745084 cites W2023872059 @default.
• W1948745084 cites W2025545342 @default.
• W1948745084 cites W2034036386 @default.
• W1948745084 cites W2059647022 @default.
• W1948745084 cites W2068171275 @default.
• W1948745084 cites W2075082363 @default.
• W1948745084 cites W2076316624 @default.
• W1948745084 cites W2079663279 @default.
• W1948745084 cites W2085989892 @default.
• W1948745084 cites W2086345133 @default.
• W1948745084 cites W2087153968 @default.
• W1948745084 cites W2092075924 @default.
• W1948745084 cites W2102194155 @default.
• W1948745084 cites W2102312517 @default.
• W1948745084 cites W2103202569 @default.
• W1948745084 cites W2108790161 @default.
• W1948745084 cites W2116363103 @default.
• W1948745084 cites W2118341353 @default.
• W1948745084 cites W2119543188 @default.
• W1948745084 cites W2120235169 @default.
• W1948745084 cites W2121267642 @default.
• W1948745084 cites W2124239768 @default.
• W1948745084 cites W2124247204 @default.
• W1948745084 cites W2126125759 @default.
• W1948745084 cites W2126805804 @default.
• W1948745084 cites W2127422554 @default.
• W1948745084 cites W2129336294 @default.
• W1948745084 cites W2133082762 @default.
• W1948745084 cites W2133416234 @default.
• W1948745084 cites W2135193555 @default.
• W1948745084 cites W2136145230 @default.
• W1948745084 cites W2137408480 @default.
• W1948745084 cites W2137978158 @default.
• W1948745084 cites W2142742490 @default.
• W1948745084 cites W2149505436 @default.
• W1948745084 cites W2156121263 @default.
• W1948745084 cites W2164547687 @default.
• W1948745084 cites W2167142042 @default.
• W1948745084 cites W2168630917 @default.
• W1948745084 cites W2198866495 @default.
• W1948745084 cites W2205577567 @default.
• W1948745084 cites W2286350689 @default.
• W1948745084 cites W2303651371 @default.
• W1948745084 cites W2312999996 @default.
• W1948745084 cites W2321986725 @default.
• W1948745084 cites W2332227009 @default.
• W1948745084 cites W2336850018 @default.
• W1948745084 cites W2342178794 @default.
• W1948745084 cites W2394553765 @default.
• W1948745084 cites W2402203869 @default.
• W1948745084 cites W2437822687 @default.
• W1948745084 cites W2475261460 @default.
• W1948745084 cites W2483196217 @default.
• W1948745084 cites W2512086803 @default.
• W1948745084 cites W2579221121 @default.
• W1948745084 cites W2626357523 @default.
• W1948745084 cites W3021842026 @default.
• W1948745084 cites W3034899365 @default.
• W1948745084 cites W3143437408 @default.
• W1948745084 cites W3150595609 @default.
• W1948745084 cites W359479911 @default.
• W1948745084 cites W4210624100 @default.
• W1948745084 cites W4214896617 @default.
• W1948745084 cites W4230361628 @default.
• W1948745084 cites W4230616336 @default.
• W1948745084 cites W4230724635 @default.
• W1948745084 cites W4246047877 @default.
• W1948745084 cites W4248581641 @default.
• W1948745084 cites W4293084779 @default.
• W1948745084 cites W4294233249 @default.
• W1948745084 cites W4302083008 @default.

• next